RecruitingNCT04664192

Bio-Banking of Specimens for Advanced Lung Disease and Lung Transplant Research


Sponsor

Baylor Research Institute

Enrollment

100 participants

Start Date

Jun 4, 2021

Study Type

OBSERVATIONAL

Conditions

Summary

A major goal of this protocol is to support biomarker studies in advanced lung diseases, lung transplantation care, and to improve our understanding of the effects of viral and other infectious exposures to outcomes in our lung transplant and ALD patient populations.


Eligibility

Min Age: 18 Years

Inclusion Criteria3

  • All individuals aged 18 years and older
  • Persons who have undergone lung transplantation at Baylor University Medical Center in the previous 10 years
  • Individual is able to understand and sign the informed consent form

Exclusion Criteria5

  • Significant documented anemia (hemoglobin \<8 g/dL)
  • Blood transfusions within past 3 weeks
  • Active cancer (non-skin cancers)
  • Enrollment against doctor recommendation
  • Patient not able to provide informed consent

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERPatient Biospecimen Registry (observational and blood sampling)

Clinical data collected at every blood sample collection visit.


Locations(1)

Baylor Scott & White Research Institute

Dallas, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04664192


Related Trials